Pro Share Advisors LLC Synlogic, Inc. Transaction History

Pro Share Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 12, 2020	SELL	$1.96 - $2.81 $20,338 - $29,159	-10,377 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$2.12 - $9.37 $21,999 - $97,232	10,377 New	10,377 $24,000
Q2 2019 Aug 13, 2019	SELL	$6.27 - $9.48 $64,712 - $97,843	-10,321 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$7.01 - $10.24 $497 - $727	71 Added 0.69%	10,321 $78,000
Q4 2018 Feb 14, 2019	BUY	$5.95 - $14.49 $60,987 - $148,522	10,250 New	10,250 $72,000

25.5K

Ticker SYBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,229,600
Market Cap $103M
Description
Synlogic, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotic medicines to treat metabolic and immunological diseases in the United States. Its therapeutic programs include SYNB1618 and SYNB1934 that are orally administered, non-systemically absorbed drug candidates, which are in Phase I...

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Pro Share Advisors LLC with notifications on news.